Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | ClH.H3NO |
| Molecular Weight | 69.491 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NO
InChI
InChIKey=WTDHULULXKLSOZ-UHFFFAOYSA-N
InChI=1S/ClH.H3NO/c;1-2/h1H;2H,1H2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. | 1993 Nov |
|
| Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma. | 1993 Oct 19 |
|
| Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime. | 1997 Aug |
|
| The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives. | 1999 Nov 1 |
|
| Molecular diffusion into ferritin: pathways, temperature dependence, incubation time, and concentration effects. | 2000 Apr |
|
| Paraquat induces different pulmonary biochemical responses in Wistar rats and Swiss mice. | 2000 Mar 1 |
|
| In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv. | 2009 Sep |
|
| Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity. | 2013 Feb 25 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HYDROXYLAMMONIUM CHLORIDE
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY | |||
|
443297
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY | |||
|
5470-11-1
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY | |||
|
m6137
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY | Merck Index | ||
|
5X4ZA62Z4Q
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY | |||
|
26250
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY | |||
|
226-798-2
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY | |||
|
DTXSID7025425
Created by
admin on Fri Dec 15 19:43:59 GMT 2023 , Edited by admin on Fri Dec 15 19:43:59 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
